Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/9068
DC FieldValueLanguage
dc.contributor.authorSpyropoulos, Alex Cen_US
dc.contributor.authorAgeno, Walteren_US
dc.contributor.authorAlbers, Gregory Wen_US
dc.contributor.authorElliott, C Gregoryen_US
dc.contributor.authorHalperin, Jonathan Len_US
dc.contributor.authorHiatt, William Ren_US
dc.contributor.authorMaynard, Gregory Aen_US
dc.contributor.authorSteg, P Gabrielen_US
dc.contributor.authorWeitz, Jeffrey Ien_US
dc.contributor.authorSuh, Eunyoungen_US
dc.contributor.authorSpiro, Theodore Een_US
dc.contributor.authorBarnathan, Elliot Sen_US
dc.contributor.authorRaskob, Gary Een_US
dc.contributor.authorMARINER Investigators*en_US
dc.contributor.authorKuzmanovska, Biljanaen_US
dc.date.accessioned2020-09-18T09:42:55Z-
dc.date.available2020-09-18T09:42:55Z-
dc.date.issued2018-09-20-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/9068-
dc.description.abstractPatients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy.en_US
dc.language.isoenen_US
dc.relation.ispartofThe New England journal of medicineen_US
dc.titleRivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illnessen_US
dc.typeArticleen_US
dc.identifier.doi10.1056/NEJMoa1805090-
dc.identifier.volume379-
dc.identifier.issue12-
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

48
Last Week
0
Last month
checked on Jul 1, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.